Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001822629-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | 2026-02-11 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $76.25 | -30.7K | 380.6K | -7% | -$2.34M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-11 | F | D | 30,659 | $76.25 | 380,560 | D | — | — |